Generic Drug Lobby: Researchers Should Focus On Low Reimbursement Not Outlier Price Hikes

October 03, 2018
The generic drug lobby, reacting to a new study by University of Southern California researchers predicting large price hikes for a small slice of generic drugs , says the researchers are focusing on the wrong issue. The lobby tells Inside Health Policy that analysts should instead study how the overall decline in generic drug prices threatens the availability of generics. “More valuable research would be to understand why the prices and reimbursement of generic drugs have gone down so...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.